Presentation of vitiligo in a case of COVID‐19 infection concomitant with receiving remdesivir

Abstract

Key Clinical Message The occurrence of vitiligo following COVID‐19 infection and vaccination is well‐documented. The mitochondrial dysfunction of melanocytes in vitiligo and the potential impact of RDV on mitochondria raise concerns about RDV possibly causing vitiligo.

Keywords

• COVID‐19 infection
• remdesivir
• vaccination
• Vitiligo